NCT03938220

Brief Summary

The aim of this study is to evaluate the diagnostic accuracy of electrical cardiometry (EC) for the noninvasive determination of fluid responsiveness in sepsis and agreement of (EC) compared to transthoracic echocardiography (TTE).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 6, 2019

Completed
26 days until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2021

Completed
Last Updated

May 3, 2022

Status Verified

April 1, 2022

Enrollment Period

2.3 years

First QC Date

April 30, 2019

Last Update Submit

April 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of electrical cardiometry to predict fluid responsiveness.

    Fluid resuscitation will be 30 mL/kg of intravenous infusion of lactated ringer to be given within the first 3 h (≈5 mL/kg/30 min) guided by fluid responsiveness (fluid responder if stroke volume increases by \> 10% after the fluid challenge). If the patient becomes fluid non-responder, vasopressor infusion (norepinephrine 0.05-0.3µg/kg/min) will start. The end of the study is when mean arterial blood pressure\> 65 mmHg (either by fluid or both fluid and vasopressor).

    24 hours

Secondary Outcomes (1)

  • Agreement of electrical cardiometry with transthoracic echocardiography in the change of stroke volume before and after fluid challenge.

    24 hours

Study Arms (2)

fluid responders

fluid responder if stroke volume increases by \> 10% after the fluid challenge

Device: Electrical Cardiometry

fluid non responders

fluid responder if stroke volume increases by \<= 10% after the fluid challenge

Device: Electrical Cardiometry

Interventions

Electrical cardiometry (EC) measurements: by the ICON\_ hemodynamic monitor (ICON Cardiotronics, Inc., La Jolla, CA 92307; Osyka Medical GmbH, Berlin, and Germany, model C3, Serial no: 1725303). Four sensors of EC will be applied (1st: 5 cm above the base of the neck, 2nd: on the base of neck, 3rd: lower thorax at the level of the xiphoid and 4th: 5 cm below the 3rd electrode at the level of anterior axillary line). The ICON continuously displays HR, SV and CO.

fluid non respondersfluid responders

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This prospective cohort study will be carried out in Tanta University Hospitals at surgical ICU

You may qualify if:

  • Age from 19 to 65 years old.
  • Clinical criteria of sepsis \[acute change in sepsis-related organ failure assessment (SOFA) variables ≥ 2 points consequent to the infection which include: PaO2/FiO2 ratio \< 300, Glasgow Coma Scale score \< 15, mean arterial pressure (MAP) \< 70 mmHg, serum creatinine \>1.2 mg/dl or urine output \< 0.5 ml/kg/h, serum bilirubin \> 1.2 mg/dL, platelet count \< 150 X 103 /µl\].
  • Developing hypotension (mean arterial blood pressure ≤ 65 mmHg).

You may not qualify if:

  • Other causes of shock
  • Previous cardiac disease
  • Rhythm other than sinus rhythm or heart rate \> 140 beats/min
  • Chronic renal failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University Hospitals

Tanta, ElGharbiaa, 31511, Egypt

Location

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

April 30, 2019

First Posted

May 6, 2019

Study Start

June 1, 2019

Primary Completion

September 10, 2021

Study Completion

September 10, 2021

Last Updated

May 3, 2022

Record last verified: 2022-04

Locations